We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NVEC:NASDAQNVE Corporation analysis

Data as of Sep 7, 2026 - not real-time

Latest price
$100.40
Risk: high
8/10High risk

Summary

At $100.40, NVE Corporation shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have lost 14.6%. With RSI at 40.5 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $96.05 and resistance at $127.84.
Multiples put this in fair territory: 27.0 times earnings against the sector's 33.2. Revenue is growing at 80.7% on a 57.6% profit margin. The 3.97% dividend yield looks stretched against payout coverage.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 48.2%, a beta of 1.46 and a maximum drawdown of 27.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.

Top market events

  • NVE Corporation recently reported first-quarter 2026 results, with revenue rising to US$11.
  • This article first appeared on GuruFocus.
  • Detailed price information for Nve Corp NVEC-Q from The Globe and Mail including charting and trades.

Market outlook

Short term

< 1 year

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 83.58
  • MACD momentum is negative

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 27.0 versus sector average of 33.2
  • Dividend yield of 3.97% looks stretched against payout coverage

Long term

> 3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • P/E of 27.0 versus sector average of 33.2
  • Dividend yield of 3.97% looks stretched against payout coverage
  • Profit margin of 57.6% is healthy

Key metrics

Financial health

Revenue Growth80.70%
Profit Margin57.64%
P/E Ratio27.0
ROE29.81%
ROA19.30%
Debt/Equity1.51
P/B Ratio8.1
Op. Cash Flow$16.8M
Free Cash Flow$7.8M
Industry P/E33.2

Technical analysis

TrendBullish
RSI40.5
Support$96.05
Resistance$127.84
MA 20$109.31
MA 50$106.34
MA 200$83.58
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair Value$60.04
GradeFair
TypeBlend
Dividend Yield3.97%

Risk assessment

Beta1.46
Volatility48.16%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.